• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
Santen Pharmaceutical released FY2026 Q2 earnings on November 6 After-Market EST, actual revenue USD 465.19 M (forecast USD 470.41 M), actual EPS USD 0.1651
00:00
Santen Pharmaceutical released FY2026 Semi-Annual Earnings on November 6 After-Market EST, actual revenue USD 940.07 M (forecast USD 925.11 M), actual EPS USD 0.2843
00:00
Oct30
Santen Pharmaceutical to Release FY2026 Q2 Earnings on November 6 After-Market EST, Forecast Revenue USD 457.85 M
00:10
Aug7
Santen Pharmaceutical released FY2026 Q1 earnings on August 7 After-Market (EST), actual revenue USD 474.84 M (forecast USD 499.7 M), actual EPS USD 0.1193
23:00
Santen Pharmaceutical (ADR) Q2 2025 Revenue Down 8.1%, Net Profit Down 44.7%
06:38
Jul31
Santen Pharmaceutical to Release FY2026 Q1 Earnings on August 7, 2025, After-Market EST; Forecast Revenue USD 503.95 M
00:08

Schedules & Filings

Schedules
Filings
Feb5
Earning Release(EST)

FY2026 Q3 Earning Release

Nov6
Earning Release(EST)

FY2026 Q2 Earning Release (USD) Revenue 465.19 M, Net Income 54.21 M, EPS 0.1651

Sep30
Distribution Plan(EST)

Cash dividend 0.1314 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More